Abstinence was the most common type of remission in probands (34.6%), with lower rates of non-abstinent remission (11.1%). In relatives, rates of non-abstinent and abstinent remission were similar (22.8% and 20.6%, respectively). Among remitted individuals, abstinent and non-abstinent remission accounted for 75.8% and 24.2% of probands and 47.5% and 52.5% of relatives, respectively. Nearly half (49.6%) of abstinent relatives and 40.9% of non-abstinent relatives had been remitted for at least 10 years; an additional 23.1% of abstinent and 20.9% of non-abstinent relatives had been remitted for 5–9 years. Among probands, who met AUD criteria at baseline, 75.2% of abstinent and 52.2% of non-abstinent individuals had been remitted for 5 years (since their baseline interview). Relatives were slightly but not significantly younger than probands when they entered the study and had a larger proportion of females (45.8% versus 25.7%, χ2(1)=5.4, p=.02). Relatives had a lower mean number of lifetime AUD symptoms than did probands, but this was not statistically significant. There were no significant differences between relatives and probands on other covariates, with the exception of professional treatment, which was not